Expertise in
5
conditions

Caroline Rousseau

Nantes, FR 
Expertise in
5
conditions
Nantes, FR 

Overview

Caroline Rousseau practices practicing medicine in Nantes, France.

Rousseau is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Prostate Cancer, Breast Cancer, Medullary Thyroid Carcinoma, Thrombectomy, and Lymphadenectomy.

They are actively involved in clinical research, co-authoring 110 peer reviewed articles and participating in 4 clinical trials.

Locations

Nantes, 44000, France
Other Locations
Saint Herblain, France
Saint Herblain
Rene, France
St Herblain, Sete, France
Angers, 44000, France
Rennes, France
185 Rue Raymond Losserand, Paris, 75674, France
Rue Du Colonel Fonferrier, Brest, 29240, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Bringing Semi-quantitative PET-TDM FDG Data and Texture Analysis to Clinical, Histological and Immuno-histochemical Characteristics of Primary Mammary Tumors Triple Negatives
Bringing Semi-quantitative PET-TDM FDG Data and Texture Analysis to Clinical, Histological and Immuno-histochemical Characteristics of Primary Mammary Tumors Triple Negatives
Enrollment Status: Unknown
Publish Date: February 21, 2023
Intervention Type: Diagnostic test
Pharmacokinetic and Imaging Optimization Study of Pretargeted Immuno-PET Using the Anti-CEA x Anti-HSG TF2 Bispecific Antibody and 68Ga-IMP-288 Peptide in Patients With Recurrences of Medullary Thyroid Carcinoma.
Pharmacokinetic and Imaging Optimization Study of Pretargeted Immuno-PET Using the Anti-CEA x Anti-HSG TF2 Bispecific Antibody and 68Ga-IMP-288 Peptide in Patients With Recurrences of Medullary Thyroid Carcinoma.
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy
Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy
Enrollment Status: Completed
Publish Date: January 07, 2019
Intervention Type: Device
Study Phase: Not Applicable
Pilot Study for Optimization of Immuno-PET Pretargeted With Anti-CEA Bispecific Antibody X Anti-HSG TF2 and the Peptide IMP-288 Radiolabeled With Gallium-68 -Pharmacokinetic and Imaging for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA
Pilot Study for Optimization of Immuno-PET Pretargeted With Anti-CEA Bispecific Antibody X Anti-HSG TF2 and the Peptide IMP-288 Radiolabeled With Gallium-68 -Pharmacokinetic and Imaging for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA
Enrollment Status: Completed
Publish Date: July 27, 2018
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

110 Total Publications

Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE).
Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE).
Journal: European journal of nuclear medicine and molecular imaging
Published: July 10, 2025

Frequently Asked Questions about Caroline Rousseau

Is Caroline Rousseau a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Caroline Rousseau is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Caroline Rousseau participate in research or clinical trials?

Yes. Caroline Rousseau has published 110 articles and abstracts on conditions like Prostate Cancer. You can view a list of Caroline Rousseau's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Rousseau's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile